Indias Turn: Understanding the Economic Transformation by Arvind SubramanianIndias Turn: Understanding the Economic Transformation by Arvind Subramanian

Indias Turn: Understanding the Economic Transformation

byArvind Subramanian

Paperback | August 1, 2009

Pricing and Purchase Info

$24.95

Earn 125 plum® points
Quantity:

In stock online

Ships free on orders over $25

Not available in stores

about

This collection analyses India's economic growth and its integration with the world economy. The essays, both analytical and prescriptive, offer fresh and unconventional answers to questions related to the turning point of India's economy, its pattern of economic development, status of publicinstitutions and its economic future. The two broad themes underlying the articles are: analysing India's economic growth and its integration with world economy. The first relates to India's current and future growth. The chapters in this section are analytical in nature detailing the Indian growth experience in the last three decades.The second relates to the integration of India into the world economy in trade in goods, in ideas, and capital flows. This unique collection offers Indian policymakers and analysts several policy options and choices.
Arvind Subramanian is Senior Fellow at the Peterson Institute for International Economics.
Loading
Title:Indias Turn: Understanding the Economic TransformationFormat:PaperbackDimensions:280 pages, 8.94 × 5.98 × 0.59 inPublished:August 1, 2009Publisher:Oxford University PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0198064063

ISBN - 13:9780198064060

Look for similar items by category:

Reviews

Table of Contents

PrefaceIntroductionSection I.1. From 'Hindu Growth' to Productivity Surge2. India's pattern of Development; What happens what Follows3. The Evolution of Institution in India and its Relationship with Economic Growth4. Why Can't India grow at Seven per cent or more?Section II.5. Uruguay Round6. Jagdish Bhagwati and India's Trade Strategy Today7. Putting some Numbers in the TRIPS Pharmaceutical Debate8. Capital Account Convertibility: A Neglected Consideration